Bristol Myers Squibb Co. Stock Rises Thursday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.03% higher to $68.20 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.57% to 4,050.83 and the Dow Jones Industrial Average rising 0.43% to 32,859.03. Bristol Myers Squibb Co. closed $13.24 below its 52-week high ($81.44), which the company achieved on December 1st.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.08% to $153.43, Pfizer Inc. (PFE) rose 0.32% to $40.38, and Abbott Laboratories (ABT) rose 0.47% to $99.08. Trading volume (4.4 M) remained 3.8 million below its 50-day average volume of 8.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 30, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 30, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.